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Objectives: The objective was to measure the rate of unintended pregnancies in women using levonorgestrel-releasing intrauterine systems
(LNG IUSs, releasing 20 mcg LNG daily) and copper intrauterine devices (IUDs) in a typical population of IUD users and to describe
associated complications.
Methods: A multinational, prospective, non-interventional cohort study of new users of LNG IUS and copper IUDs was performed.
Following a baseline survey, study participants and their physicians completed one follow-up questionnaire after 12 months. A multifaceted
four-level follow-up procedure minimized loss to follow-up. Patient-reported outcomes were validated by the treating physicians.
Results: A total of 61,448 women with a newly inserted IUD were enrolled in six European countries between 2006 and 2012. The copper
IUD cohort contained more than 30 different types. Validated 1-year follow-up information for 58,324 users between 18 and 50 years of age
(70% using LNG IUS, 30% using copper IUDs) was collected. A total of 118 contraceptive failures occurred (26 LNG, 92 copper). Both
types of IUD were highly effective, with overall Pearl indices of 0.06 [95% confidence interval (CI): 0.04–0.09] and 0.52 (95% CI:
0.42–0.64) for LNG IUS and copper IUDs, respectively. The adjusted hazard ratio for LNG IUS vs. copper IUDs was 0.16 (95% CI:
0.10–0.25). Tenty-one pregnancies (7 LNG IUS, 14 copper IUD) were ectopic, yielding an adjusted hazard ratio for ectopic pregnancy of
0.26 (95% CI: 0.10–0.66).
Conclusions: The contraceptive failure rate was low with both IUDs. However, the LNG IUS was associated with a significantly lower risk
of pregnancy, including ectopic pregnancy, than the copper IUDs.
Implications: To our knowledge, this is the first large-scale, multinational, prospective epidemiological study to measure and compare the
contraceptive effectiveness of LNG IUSs and copper IUDs during routine clinical practice. Clinicians and patients should be aware of
differences in rates of unintended pregnancies and associated complications in relation to IUD us.
© 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
licenses/by-nc-nd/4.0/).Keywords: Intrauterine device (IUD); Levonorgestrel (LNG); Copper; Ectopic pregnancy; EURAS IUD1. Introduction
Contraceptive failure rates for both copper intrauterine
devices (IUDs) and levonorgestrel-releasing intrauterine
systems (LNG IUSs) are among the lowest for reversible
methods of contraception [1,2], with studies of various types
showing rates of around 0.1–2.2 per 100 WY for copper⁎ Corresponding author at: ZEG-Berlin Center for Epidemiology and
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licenses/by-nc-nd/4.0/).IUDs and 0.1–0.6 per 100 WY for LNG IUSs [3–10]. The
respective ectopic pregnancy rates range from 0.02–0.2 in
LNG IUS users and from 0.1–0.8 in copper IUD users
[3,4,8,11].
Results from large-scale prospective studies on contra-
ceptive effectiveness and pregnancy-related outcomes,
including ectopic pregnancies, have not previously been
available for LNG IUS or for LNG IUS in comparison to
copper IUDs. This article presents the final results on
pregnancy-related outcomes from the European Active
Surveillance Study for Intrauterine Devices (EURAS IUD).
Results on uterine perforation from the EURAS IUD study
are reported separately [12].ess article under the CC BY-NC-ND license (http://creativecommons.org/
281K. Heinemann et al. / Contraception 91 (2015) 280–283The objective of this article was to compare the contracep-
tive effectiveness and pregnancy-related outcomes, including
ectopic pregnancies, for users of LNG and copper IUDs.2. Methods
The purpose of the EURAS IUD was to identify and
compare the risks of LNG IUS and copper IUD use in a
population of typical users of IUDs. The methods are
described in detail elsewhere [12]. The primary outcome of
interest in EURAS IUD was the incidence of uterine
perforation. A further a priori objective of the EURAS IUD
study (and the focus of this article) was to compare the
contraceptive effectiveness and pregnancy-related out-
comes for users of LNG versus copper IUDs, including
ectopic pregnancies.
EURAS IUD was a multinational, prospective, con-
trolled, long-term cohort study with recruitment in six
European countries (Austria, Finland, Germany, Poland,
Sweden, UK) from 2006 to 2012. Its two cohorts consisted
of new users of LNG and copper IUDs.
A non-interference approach was chosen; participating
health care providers prescribed and provided the method as
they normally would. The EURAS IUD study was approved
by the ethical committee of the physicians' association in
Berlin, Germany, and the Ethics Committee of Hospital
District of Southwest Finland. The other participating
countries accepted these approvals. The final results of
this study were reported to the European Medicines
Agency, to the US Food and Drug Administration and
other health authorities.
Recruitment of study participants was conducted via a
network of health care professionals (HCPs), such as
gynecologists and midwives who regularly insert IUDs,
either office based or in specialized clinics. All women with
a newly inserted IUD were eligible for enrollment.
Therefore, the copper IUD cohort consists of numerous
different types of copper IUDs primarily characterized here
by their surface area (b300 mm2, ≥300 mm2). After the
decision to initiate an IUD was made, participating HCPs
asked the women whether they were willing to participate in
the study. Because of the non-interference approach,
eligibility criteria were minimal: these included a willingness
to sign an informed consent form and data privacy form, and
an absence of a language barrier that could prevent the
patient from completing the questionnaires.
At the time of IUD insertion, study participants completed
a baseline questionnaire on which they recorded information
about their state of health and potential risk factors. These
included medical and lifetime reproductive history, medica-
tion history, history of contraceptive use, age, body mass
index (BMI), smoking, alcohol, exercise and lifting of heavy
objects, and level of education. Study participants and the
inserting HCP received a follow-up questionnaire 12 months
after enrollment. The follow-up survey recorded informationabout any potential complications associated with the IUD,
medical checkups, illnesses, hospitalization and pregnancy
that occurred during the time period since IUD insertion.
All events and pregnancy-related outcomes reported by
study participants, including subjectively perceived symp-
toms and the diagnoses as understood by them, were entered
into the study database. These report forms were immedi-
ately passed on to the study center’s medical reviewer or
review group, which contacted the participants for clarifica-
tion if necessary and the treating physicians for validation.
The follow-up questionnaire sent to physicians 12 months
after insertion recorded any pregnancy outcomes in addition
to examination dates, IUD position (including unnoticed
expulsion), uterine perforation, complications and patients’
medical conditions.
The sample size of this study was chosen to test
noninferiority of LNG IUS regarding the perforation risk
(the primary outcome of interest in this study) in comparison
to copper IUDs. Sample size calculations showed that 60,000
participants would be sufficient to exclude a 1.7-fold risk.
These calculations were based on an estimated perforation
rate of 0.5 per 1000 insertions, a one-sided α of 0.025 and a
power (1−β) of 0.80.
Crude as well as adjusted hazard ratios (HRs) were
calculated. The appropriate confounding variables were built
into the model. Based on the expectation of a small absolute
number of unintended pregnancies, the confounding vari-
ables were limited to a small number of predefined risk
factors (age, BMI, parity) recommended by the independent
Safety Monitoring and Advisory Council. All analyses were
performed with the statistical package STATA 9.0.3. Results
Recruitment started in Germany, Austria and Finland in
2006, the United Kingdom in 2008, Sweden in early 2009
and Poland in November 2009. Recruitment stopped at the
end of 2012. In total, 61,448 women with a newly inserted
IUD were enrolled by more than 1200 participating HCPs. In
total, 1235 women, or 2.0% (1.7% for LNG IUS, 2.8% for
copper IUD), were lost to follow-up during the 1-year
follow-up period. For all analyses regarding unplanned
pregnancies, only women in the age group of 18–50 years
were included. This analysis includes validated follow-up
information for a total of 58,324 women in this age group:
41,001 users of LNG IUS and 17,323 users of copper IUDs,
resulting in 44,633 and 17,703 WYs of observation,
respectively. More than 30 types of copper IUDs were
included in the copper IUD cohort, the most frequent ones
being NovaT (200 or 380) with 37%, T Safe Cu 380 with
18% and Multiload CU (250 or 375) with 14%. The copper
surface areas were less than 300 mm2, 300 mm2 and more
than 300 mm2 in 7.8%, 1.6% and 71.3% of the inserted
copper IUDs inserted in this study, respectively. In 19.3%,
the surface area was not known.



















ig. 1. Relative risk of contraceptive failure and of ectopic pregnancy in
NG IUS compared to copper IUD users: Adjusted* HR (95% CI).
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mean ages of 37.4 and 33.3 years, respectively. More than
40% of the LNG IUS users in this study were over 40 years
of age, as compared to only 24% in the copper IUD group.
Another difference between cohorts with potential impact on
contraceptive failure included the prevalence of breastfeed-
ing at time of insertion (9.2% vs. 14.6%). In the LNG IUS
cohort, 19.8% of users had given birth during the 12 months
preceding insertion, compared to 28.7% of copper IUD
users. Some 93.0% of the LNG IUS users and 88.0% of the
copper IUD users had ever been pregnant. The proportion of
smokers in both cohorts was comparable. The educational
level of the copper IUD users and LNG IUS users was
comparable: 55.6% of the copper IUD users had at least
university entrance level, compared to 49.6% of the LNG
IUS users. More detailed information about baseline
characteristics has been reported separately [12].
One hundred eighteen validated, unintended pregnan-
cies occurred during the 1-year follow-up period: 26 in
LNG IUS users and 92 in copper IUD users. Twenty-nine of
these unintended pregnancies (13 LNG IUS, 16 copper
IUD) occurred after an unrecognized IUD expulsion and
were therefore considered to have resulted from a failure of
the contraceptive method. They were therefore included in
this analysis.
In 27 pregnant women (1 LNG IUS, 26 copper IUD), the
IUD was found dislocated (not in the uterine cavity, but
still in the body). While it is possible to attribute
dislocation of the IUD to the mechanical forces of the
pregnancy itself, over 80% of these cases were diagnosed
in the very early stages of pregnancy (6 weeks or less after
conception), most likely before the position of the IUD
could have been affected.
In three cases of unintended pregnancy (three copper
IUD) the IUD was perforated. The remaining unintended
pregnancies occurred with the IUD entirely within the uterus.
Contraceptive failure rates differed markedly between
cohorts. The overall Pearl index (PI; pregnancies per 100
WYs) in the LNG IUS cohort was 0.06 [95% confidence
interval (CI): 0.04–0.09); the respective PI for the copper
IUD users was 0.52 (95% CI: 0.42–0.64). The life-table
estimates of the rate of contraceptive failure for the first year
of use were 0.07% and 0.63% for LNG IUS and copper IUD,
respectively.
This resulted in a crude risk ratio for LNG IUS use
compared to copper IUD use of 0.11 (95% CI: 0.07–0.17).
To control for potential differences in contraceptive failure
rates associated with different surface areas in the copper
IUD cohort, stratified analyses were conducted using
300 mm2 as the cutoff point (b300 mm2, ≥300 mm2).
The pearl indices for copper IUD with less than 300 mm2
was 0.56 (95% CI: 0.24–1.09), and 0.62 (95% CI:
0.50–0.78) for 300 mm2 or greater.
Age distribution differed markedly between cohorts, so
the life-table estimates of the rate of contraceptive failure for
the first year of use for the cohorts were therefore calculatedF
Lstratified by age groups (18–b30 years, 30–b40 years,
40–50 years) (Table 1). The respective estimate for LNG
IUS and copper users in the age group of 18–35 years was
0.15 and 0.97, respectively. The risk of contraceptive failure
in LNG IUS users compared to copper IUD users was
statistically significantly lower in all age groups except for
women between 40 and 50 years of age.
Stratification by country also showed statistically signif-
icantly lower risks for LNG IUS users compared to copper
IUD users in all countries except for Poland, where the
sample size was too small. In Poland, no pregnancies with
LNG IUS occurred, and there were four pregnancies with
copper IUDs (data not shown).
Cox regression analysis that included the predefined
prognostic factors age, BMI, and parity yielded an adjusted
HR of 0.16 (95% CI: 0.10–0.25) for LNG vs. copper IUDs
(Fig. 1). The same comparison excluding those pregnancy
cases with an unnoticed expulsion of the IUD yielded an
adjusted HR of 0.10 (95% CI: 0.05–0.18).
Significant differences between cohorts were evident in
the ectopic pregnancy rates. Seven women with LNG IUS
and 14 women with copper IUDs had an ectopic pregnancy,
resulting in incidence rates of 0.02 per 100 WY (95% CI:
0.01–0.03) and 0.08 per 100 WY (95% CI: 0.04–0.13),
respectively. The proportion of ectopic pregnancies among
all contraceptive failure pregnancies was higher in LNG IUS
users compared to copper IUD users (27% vs. 15%, p = .16),
but due to the substantially lower risk of contraceptive failure
in LNG IUS users, the overall risk for ectopic pregnancies
was significantly lower in LNG IUS users compared to
copper IUD users [HR 0.20 (95% CI: 0.08–0.48)]. The HR
did not change substantially after adjustment for age, BMI
and parity [HR 0.26 (95% CI: 0.10–0.66)] (Fig. 1).
Two of the seven ectopic pregnancies in LNG IUS users
and 10 of the 14 ectopic pregnancies in copper IUD users
resulted in a salpingectomy. In addition, two of the
extrauterine pregnancies in copper IUD users led to removal
of an ovary.
Table 1
Life-table estimates for contraceptive failure in first year of use by IUD cohort by age group
Age group LNG IUD Copper IUD
No. of pregnancies LT est. (95% CI) No. of pregnancies LT est. (95% CI)
18–b30 years 7 0.16 (0.03–0.28) 54 1.35 (0.95–1.76)
N = 30–b40 years 16 0.12 (0.06–0.18) 36 0.57 (0.37–0.77)
N = 40–b51 years 3 0.01 (0–0.03) 2 0.05 (0–0.12)
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The contraceptive effectiveness was very high in both
cohorts in this study. However, use of LNG IUS in this study
was associated with one eighth the incidence of pregnancy
during the first year of use, including a marked reduction in
ectopic pregnancy, compared to use of a copper IUD. A
discrepancy this large is unlikely to be explained by effects
of selection bias or information bias [13–16]. Differential
losses to follow-up are also unlikely to have caused the
disparity: the study achieved a low overall loss to follow-up
with 1.7% and 2.8% in the LNG IUS and copper IUD users,
respectively. Our analysis controlled for important potential
confounding factors, and the results were unchanged. The
significantly lower risk for ectopic pregnancy in LNG IUS
users compared to copper IUD users is not likely to be due to
chance. Hence, we believe these findings are robust.
A wide range of pearl indices for LNG IUS has been
reported in the scientific literature. A cross-sectional study
by Backman in more than 17,000 women, for example,
showed a PI of 0.11 [4]. Similar results of 0.1–0.2 were
found in reviews of randomized clinical trials [7–9]. Other
authors have found higher rates of contraceptive failure.
Cox, for example, found a PI of 0.6 in an open-label,
single-group study in almost 600 women [6].
As in our study, PIs for various copper IUD systems are
generally found to be higher than those for LNG IUS, although
not necessarily to the extent that we found here. A Cochrane
review of randomized controlled trials reported PIs of 0.5–2.2
for copper IUDswith a surface area of less than 300 mm2, and
of 0.1–1.0 for greater than 300 mm2 [5]. Sivin et al. and
Mansour et al. reviewed several randomized clinical trials
and found results in the same range [8,10]. Two additional
randomized clinical trials in more than 2000 women,
respectively, showed similar PIs of 0.3–1.3 [3,7].
These results on ectopic pregnancies are consistent with
findings from other studies. Previously reported ectopic
pregnancy rates for LNG IUS users ranged from 0.02 to 0.2
per 100WY, and rates for copper IUD users were from 0.1 to
0.8 per 100 WY [3,4,8,11].
In this study, we collected no information on concurrent
use of other contraceptive methods. However, use of
additional contraceptive methods is probably more prevalent
in younger women not yet living in stable partnerships. As
the copper IUD cohort was markedly younger, this would
probably have led to an underestimation of the risk ratio
rather than an overestimation.This epidemiological study investigated routine clinical
practice in an international environment and probably allows
extrapolation toother populations. Thegreater effectiveness of the
LNGIUSwas evident for all age groups ofwomenand is unlikely
to be due to bias, confounding or chance. Clinicians and women
seeking contraception need to be aware of these differences in the
contraceptive effectiveness in contemporary IUDs.
References
[1] Winner B, Peipert JF, Zhao Q, Buckel C, Madden T, Allsworth JE, et al.
Effectiveness of long-acting reversible contraception. N Engl J Med
2012;366(21):1998–2007.
[2] Trussell J. Contraceptive failure in the United States. Contraception
2011;83(5):397–404.
[3] Andersson K, Odlind V, Rybo G. Levonorgestrel-releasing and
copper-releasing (Nova T) IUDs during five years of use: a randomized
comparative trial. Contraception 1994;49(1):56–72.
[4] Backman T, Rauramo I, Huhtala S, Koskenvuo M. Pregnancy during
the use of levonorgestrel intrauterine system. Am J Obstet Gynecol
2004;190(1):50–4.
[5] Kulier R, O'Brien PA, Helmerhorst FM, Usher-Patel M, D'Arcangues C.
Copper containing, framed intra-uterine devices for contraception.
Cochrane Database Syst Rev 2007;4:1-152 [CD005347].
[6] Cox M, Blacksell S. Clinical performance of the levonorgestrel intra-
uterine system in routine use by the UK Family Planning and
Reproductive Health Research Network: 12-month report. Br J Fam
Plann 2000;26(3):143–7.
[7] Sivin I, elMahgoub S,McCarthy T,Mishell Jr DR, ShoupeD, Alvarez F,
et al. Long-term contraception with the levonorgestrel 20 mcg/day (LNg
20) and the copper T 380Ag intrauterine devices: a five-year randomized
study. Contraception 1990;42(4):361–78.
[8] Sivin I. Dose- and age-dependent ectopic pregnancy risks with
intrauterine contraception. Obstet Gynecol 1991;78(2):291–8.
[9] Stoddard A, McNicholas C, Peipert JF. Efficacy and safety of long-
acting reversible contraception. Drugs 2011;71(8):969–80.
[10] Mansour D, Inki P, Gemzell-Danielsson K. Efficacy of contraceptive
methods: a review of the literature. Eur J Contracept Reprod Health
Care 2010;15(1):4–6.
[11] Ganacharya S, Bhattoa HP, Batár I. Ectopic pregnancy among non-
medicated and copper-containing intrauterine device users: a 10-year
follow-up. Eur J Obstet Gynecol Reprod Biol 2003;111(1):78–82.
[12] Heinemann K, Reed SR, Moehner S, Thai DM. Risk of uterine perforation
with levonorgestrel-releasing and copper intrauterine devices in the
European Active Surveillance Study on Intrauterine Devices. Contracep-
tion 2015;91(4):274–9.
[13] TaubesG. Epidemiology faces its limits. Science 1995;269(5221):164–9.
[14] Hill AB. The environment and disease: association or causation? Proc
R Soc Med 1965;58:295–300.
[15] GrimesDA, SchulzKF. False alarms and pseudo-epidemics: the limitations
of observational epidemiology. Obstet Gynecol 2012;120(4):920–7.
[16] Khoury MJ, James LM, Flanders WD, Erickson JD. Interpretation of
recurring weak associations obtained from epidemiologic studies of
suspected human teratogens. Teratology 1992;46(1):69–77.
